A carregar...
PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target
Soft tissue sarcomas (STSs) are aggressive tumors with few efficient systemic therapies. Poly(ADP‐ribose) polymerase‐1 (PARP1) inhibitors represent an emerging therapeutic option in tumors with genomic instability. The genomics of STSs is complex in more than half of cases, suggesting a high level o...
Na minha lista:
| Publicado no: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599836/ https://ncbi.nlm.nih.gov/pubmed/31131495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12522 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|